Combining anti-PD-1 antibodies with surufatinib for gastrointestinal neuroendocrine carcinoma: Two cases report and review of literature
The combination of antiangiogenic targeted drugs and immunotherapy provides a new therapeutic approach for the treatment of metastatic GI-NECs.
Authors
- Harvey Yuan
- Jiayuan Peng (ORCID: https://orcid.org/0000-0002-2564-2005)
- Dong-Ni Gao
- Wenqiang Chen (ORCID: https://orcid.org/0000-0001-6148-5708)
- Likun Gao (ORCID: https://orcid.org/0000-0002-9445-9458)
- Jing Yang (ORCID: https://orcid.org/0009-0003-2199-8623)
Institutions
- Shandong Tumor Hospital (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- World Journal of Clinical Oncology
- Published
- 2025-03-26
- DOI
- https://doi.org/10.5306/wjco.v16.i4.102297
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00